Category: Cannabis Markets

Since medical cannabis became available to patients in the Czech Republic in 2015, more than 1,200 kilograms have been dispensed by 2025, with the average monthly number of patients steadily increasing every year. In May 2025, the Czech Republic became the fourth country in Europe to approve a national adult-use cannabis legalization measure.

France is progressing towards establishing a permanent regulatory framework for the medical cannabis market which could generate €806 million in annual revenue by 2035.

Cannabis is legal in Switzerland for medical purposes and the country is currently running seven pilot trials for adult-use cannabis with around 104,000 active participants as of June 2025. Switzerland is also in the process of drafting a new law that if approved would legalize adult-use cannabis use and establish a regulated commercial market.

As of March 2026, some form of medical cannabis (or cannabis-based medicine) is legal in 25 countries across the region, with a further 9 having decriminalised the personal use of cannabis, and 4 having legalised cannabis for recreational use. The European cannabis market grew from €870 million in 2024 to €1.45 billion in 2025 and is projected to surpass €2 billion by 2027.